In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $56.07 in the prior trading day, CVS Health Corp (NYSE: CVS) closed at $55.15, down -1.64%. In other words, the price has decreased by -$1.64 from its previous closing price. On the day, 12.68 million shares were traded. CVS stock price reached its highest trading level at $56.0 during the session, while it also had its lowest trading level at $54.48.
Ratios:
Our goal is to gain a better understanding of CVS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.14. For the most recent quarter (mrq), Quick Ratio is recorded 0.59 and its Current Ratio is at 0.80. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 1.00.
On November 18, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $60 to $66.
Barclays Upgraded its Equal Weight to Overweight on October 10, 2024, whereas the target price for the stock was revised from $63 to $82.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’24 when LUDWIG EDWARD J bought 1,000 shares for $53.88 per share. The transaction valued at 53,879 led to the insider holds 21,630 shares of the business.
Mahoney Michael F bought 9,181 shares of CVS for $500,294 on May 02 ’24. The Director now owns 9,356 shares after completing the transaction at $54.49 per share. On Feb 16 ’24, another insider, Shah Prem S, who serves as the EVP and Pres-Pharm, Consumer W of the company, sold 29,473 shares for $76.95 each. As a result, the insider received 2,267,947 and left with 39,765 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 70558908416 and an Enterprise Value of 142587183104. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.01, and their Forward P/E ratio for the next fiscal year is 8.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.19 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 0.388 whereas that against EBITDA is 10.102.
Stock Price History:
Over the past 52 weeks, CVS has reached a high of $83.25, while it has fallen to a 52-week low of $52.71. The 50-Day Moving Average of the stock is -6.49%, while the 200-Day Moving Average is calculated to be -10.93%.
Shares Statistics:
The stock has traded on average 11.65M shares per day over the past 3-months and 9387830 shares per day over the last 10 days, according to various share statistics. A total of 1.26B shares are outstanding, with a floating share count of 1.26B. Insiders hold about 0.20% of the company’s shares, while institutions hold 82.21% stake in the company. Shares short for CVS as of 1732838400 were 17771960 with a Short Ratio of 1.84, compared to 1730332800 on 21854042. Therefore, it implies a Short% of Shares Outstanding of 17771960 and a Short% of Float of 1.4099999.
Dividends & Splits
In the trailing 12 months, CVS’s forward annual dividend rate was 2.6, compared to 2.66 this year. Against a Trailing Annual Dividend Yield of 0.046370607The stock’s 5-year Average Dividend Yield is 2.98.
